www.fdanews.com/articles/138328-the-big-bet-on-seattle-genetics
The Big Bet on Seattle Genetics
July 12, 2011
Seattle Genetics lists seven drugs on its pipeline page. And there are another 11 clinical-stage drug candidates and quite a few preclinical ones being developed by partners from large companies, such as Roche, Pfizer and Abbott, in addition to smaller ones like Progenics Pharmaceuticals and Celldex Therapeutics.
The Motley Fool
The Motley Fool